FierceBiotechCodex · 实盘不做把握 8/10
北京时间·🕒 发布 07-19 14:44:00时区推断·⟳ 抓取 23:45:57·⚡ 决策 07-20 23:51:37 +5m40s·98.8 天前
雅培癌症诊断和LabCentral业务遭网络攻击但称无重大业务影响
公司称攻击不影响运营、产品供应、制造、实验室运营或服务患者能力。
📄 原文FierceBiotech↗ 原文
Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businesses
Abbott has been struck by a cyberattack that targeted the medtech giant’s cancer diagnostics and LabCentral businesses.…
不做 雅培（ABT.US）
网络攻击方向偏负面但公司称无重大运营或财务影响，未满足强空催化和做空红线，不做；已有多头可留意后续数据泄露风险。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-16 · 扩散 medium · price-in 风险 medium ↗
关键理由
- 公司称攻击不影响运营、产品供应、制造、实验室运营或服务患者能力。
- 雅培同时表示不预计对业务或财务产生重大影响，当前缺乏可交易的强负面催化。
主要风险
- 若后续披露患者数据泄露、监管罚款或停摆，负面影响可能扩大。
反向证据
- 做空前查反向 · 来源 news · 日期 2026-07-20 · 影响 weakens
公司已明确称不预计重大业务或财务影响，削弱做空依据。
检索:Abbott cyberattack no material impact operations product availability 原文 ↗
原文全文
展开原文 · 2,174 字
Abbott has been struck by a cyberattack that targeted the medtech giant’s cancer diagnostics and LabCentral businesses.
Abbott revealed the first attack on July 16 when it said in a statement that its cancer diagnostics business was hit by a “cyber incident in which there was unauthorized access to a limited number of internal systems.”
The company added that it would be taking action to investigate the information that was accessed and to resolve the issue with the help of both law enforcement and third-party cybersecurity experts.
Abbott said that the cancer diagnostics attack “does not impact any business operations, product or product availability, manufacturing or lab operations, or our ability to serve patients.”
This unit includes Exact Sciences, which Abbott spent $21 billion on snapping up this year. The legacy Exact Sciences systems are separate from Abbott's, according to the statement.
The company also asserts that no material impact on its business or finances is anticipated and emphasizes that it will continue close monitoring of its systems moving forward.
But Abbott also said that as part of this attack it found one connected to its third-party facing LabCentral portal that contains publicly available information.
According to Reuters, a hacker had allegedly gained access to the LabCentral portal, but Abbott said here too there had been no impact to its customers or its business.
This is the latest in a series of other cyberattacks on patient data systems that have occurred throughout the year.
The most recent of these attacks targeted medical device company iRhythm, when an individual obtained patient protected health information and other personal information through the company’s systems in June. The company was threatened with demands for payment from the perpetrator, who claimed the information would otherwise be disclosed to the public.
Other companies have faced problems after similar incidents, such as the global medtech company Stryker, which experienced financial setbacks after a cyberattack this past March, including higher manufacturing and supply chain costs, as well as a drop in adjusted earnings per share.
Abbott revealed the first attack on July 16 when it said in a statement that its cancer diagnostics business was hit by a “cyber incident in which there was unauthorized access to a limited number of internal systems.”
The company added that it would be taking action to investigate the information that was accessed and to resolve the issue with the help of both law enforcement and third-party cybersecurity experts.
Abbott said that the cancer diagnostics attack “does not impact any business operations, product or product availability, manufacturing or lab operations, or our ability to serve patients.”
This unit includes Exact Sciences, which Abbott spent $21 billion on snapping up this year. The legacy Exact Sciences systems are separate from Abbott's, according to the statement.
The company also asserts that no material impact on its business or finances is anticipated and emphasizes that it will continue close monitoring of its systems moving forward.
But Abbott also said that as part of this attack it found one connected to its third-party facing LabCentral portal that contains publicly available information.
According to Reuters, a hacker had allegedly gained access to the LabCentral portal, but Abbott said here too there had been no impact to its customers or its business.
This is the latest in a series of other cyberattacks on patient data systems that have occurred throughout the year.
The most recent of these attacks targeted medical device company iRhythm, when an individual obtained patient protected health information and other personal information through the company’s systems in June. The company was threatened with demands for payment from the perpetrator, who claimed the information would otherwise be disclosed to the public.
Other companies have faced problems after similar incidents, such as the global medtech company Stryker, which experienced financial setbacks after a cyberattack this past March, including higher manufacturing and supply chain costs, as well as a drop in adjusted earnings per share.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。